VIRP.PA
Virbac SA
Price:  
305.50 
EUR
Volume:  
3,784.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRP.PA Intrinsic Value

27.40 %
Upside

Is VIRP.PA undervalued or overvalued?

As of 2025-03-21, the Intrinsic Value of Virbac SA (VIRP.PA) is 389.16 EUR. This VIRP.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 305.50 EUR, the upside of Virbac SA is 27.40%. This means that VIRP.PA is undervalued by 27.40%.

The range of the Intrinsic Value is 258.79 - 781.46 EUR

305.50 EUR
Stock Price
389.16 EUR
Intrinsic Value
Intrinsic Value Details

VIRP.PA Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 258.79 - 781.46 389.16 27.4%
DCF (Growth 10y) 307.32 - 857.08 445.25 45.7%
DCF (EBITDA 5y) 146.36 - 246.84 196.62 -35.6%
DCF (EBITDA 10y) 202.03 - 318.12 257.96 -15.6%
Fair Value 1,430.66 - 1,430.66 1,430.66 368.30%
P/E 217.00 - 1,030.08 551.08 80.4%
EV/EBITDA 181.84 - 1,548.25 726.25 137.7%
EPV 298.47 - 393.60 346.04 13.3%
DDM - Stable 697.88 - 2,601.75 1,649.82 440.0%
DDM - Multi 244.16 - 700.60 361.26 18.3%

VIRP.PA Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 2,563.15
Beta 0.52
Outstanding shares (mil) 8.39
Enterprise Value (mil) 2,809.96
Market risk premium 5.82%
Cost of Equity 6.86%
Cost of Debt 4.25%
WACC 6.68%